The Role of Cyclin B3 in Mammalian Meiosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Migration-Selection Balance Drives Genetic Differentiation in Genes Associated with High-Altitude Function in the Speckled
GBE Migration-Selection Balance Drives Genetic Differentiation in Genes Associated with High-Altitude Function in the Speckled Teal (Anas flavirostris) in the Andes Downloaded from https://academic.oup.com/gbe/article-abstract/10/1/14/4685994 by University of Texas at El Paso user on 18 January 2019 Allie M. Graham1,*, Philip Lavretsky2, Violeta Munoz-Fuentes~ 3,4,AndyJ.Green4,RobertE.Wilson5,and Kevin G. McCracken1,5,6,7 1Department of Biology, University of Miami 2Department of Biological Sciences, University of Texas El Paso 3European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom 4Estacion Biologica de Donana,~ EBD-CSIC, Sevilla, Spain 5Institute of Arctic Biology and University of Alaska Museum, University of Alaska, Fairbanks 6Rosenstiel School of Marine and Atmospheric Sciences, University of Miami 7John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine *Corresponding author: E-mail: [email protected]. Accepted: November 30, 2017 Data deposition: DNA sequence GenBank accession information is available in supplementary table S2, Supplementary Material online. Parsed Illumina reads for the RAD-Seq data sets are already available through NCBI short read archive (SRA PRJEB11624). Abstract Local adaptation frequently occurs across populations as a result of migration-selection balance between divergent selective pressures and gene flow associated with life in heterogeneous landscapes. Studying the effects of selection and gene flow on the adaptation process can be achieved in systems that have recently colonized extreme environments. This study utilizes an endemic South American duck species, the speckled teal (Anas flavirostris), which has both high- and low-altitude populations. -
Identification of the Binding Partners for Hspb2 and Cryab Reveals
Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity. -
Relationship Between Sequence Homology, Genome Architecture, and Meiotic Behavior of the Sex Chromosomes in North American Voles
HIGHLIGHTED ARTICLE | INVESTIGATION Relationship Between Sequence Homology, Genome Architecture, and Meiotic Behavior of the Sex Chromosomes in North American Voles Beth L. Dumont,*,1,2 Christina L. Williams,† Bee Ling Ng,‡ Valerie Horncastle,§ Carol L. Chambers,§ Lisa A. McGraw,** David Adams,‡ Trudy F. C. Mackay,*,**,†† and Matthew Breen†,†† *Initiative in Biological Complexity, †Department of Molecular Biomedical Sciences, College of Veterinary Medicine, **Department of Biological Sciences, and ††Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina 04609, ‡Cytometry Core Facility, Wellcome Sanger Institute, Hinxton, United Kingdom, CB10 1SA and §School of Forestry, Northern Arizona University, Flagstaff, Arizona 86011 ORCID ID: 0000-0003-0918-0389 (B.L.D.) ABSTRACT In most mammals, the X and Y chromosomes synapse and recombine along a conserved region of homology known as the pseudoautosomal region (PAR). These homology-driven interactions are required for meiotic progression and are essential for male fertility. Although the PAR fulfills key meiotic functions in most mammals, several exceptional species lack PAR-mediated sex chromosome associations at meiosis. Here, we leveraged the natural variation in meiotic sex chromosome programs present in North American voles (Microtus) to investigate the relationship between meiotic sex chromosome dynamics and X/Y sequence homology. To this end, we developed a novel, reference-blind computational method to analyze sparse sequencing data from flow- sorted X and Y chromosomes isolated from vole species with sex chromosomes that always (Microtus montanus), never (Microtus mogollonensis), and occasionally synapse (Microtus ochrogaster) at meiosis. Unexpectedly, we find more shared X/Y homology in the two vole species with no and sporadic X/Y synapsis compared to the species with obligate synapsis. -
Stage of the Meiotic Prophase (Dictyate Stage) from Embryonic Life
In vivo change in the germinal vesicle of the sow oocyte during the follicular phase before the ovulatory LH surge Marie-Christine DAGUET Université Pierre et Marie Curie (Paris VI) and 1. N. R. A. 78350 Jouy-en-Josas, France. Summary. This study describes a morphological change in the germinal vesicle (GV) of the sow oocyte during the follicular phase preceding the ovulatory LH surge. Estrus synchronization obtained with methallibure treatment provided a reference point for dating the onset of the follicular phase of each sow in the experiment. The oocyte GV’s of preovula- tory follicles having a diameter of less than 2 mm (during the first 2 to 3 days of the follicular phase) showed uniformly dispersed chromatin with no condensation, while the GV’s of oocytes from preovulatory follicles of more than 2 mm diameter (from days 2 and 3 of the follicular phase to day 5) presented condensed chromatin in the shape of a crown or horse- shoe surrounding the nucleolus, and irregular chromatin clusters in the nucleoplasm ; these clusters were usually found lying against the nuclear membrane. Introduction. The oocyte nucleus, called the germinal vesicle (GV), remains at the diplotene stage of the meiotic prophase (dictyate stage) from embryonic life to the time of the ovulatory LH surge, permitting resumption of meiosis at each cycle in oocytes within suitable follicles. The literature contains many references to GV breakdown and change resulting from the ovulatory LH surge, i. e. the first stages of the resumption of meiosis (rats : Odor, 1955 ; Mandl, 1963 ; mice : Edwards and Gates, 1959 ; Donahue, 1968 ; sows : Spalding et at., 1955 ; Hunter and Polge, 1966 ; McGaughey and Polge, 1971 ; Motlik and Fulka, 1976), but little has been published on the development of the GV of oocytes from preovulatory follicles before the ovulatory LH surge. -
Ythdc2 Is an N6-Methyladenosine Binding Protein That Regulates Mammalian Spermatogenesis
Cell Research (2017) 27:1115-1127. © 2017 IBCB, SIBS, CAS All rights reserved 1001-0602/17 $ 32.00 ORIGINAL ARTICLE www.nature.com/cr Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis Phillip J Hsu1, 2, 3, *, Yunfei Zhu4, *, Honghui Ma1, 2, *, Yueshuai Guo4, *, Xiaodan Shi4, Yuanyuan Liu4, Meijie Qi4, Zhike Lu1, 2, Hailing Shi1, 2, Jianying Wang4, Yiwei Cheng4, Guanzheng Luo1, 2, Qing Dai1, 2, Mingxi Liu4, Xuejiang Guo4, Jiahao Sha4, Bin Shen4, Chuan He1, 2, 5 1Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA; 2Howard Hughes Medical Institute, The University of Chicago, Chicago, IL 60637, USA; 3Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA; 4State Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing 211166, China; 5Department of Biochemistry and Molecular Biology, The University of Chi- cago, Chicago, IL 60637, USA N6-methyladenosine (m6A) is the most common internal modification in eukaryotic mRNA. It is dynamically in- stalled and removed, and acts as a new layer of mRNA metabolism, regulating biological processes including stem cell pluripotency, cell differentiation, and energy homeostasis. m6A is recognized by selective binding proteins; YTHDF1 and YTHDF3 work in concert to affect the translation of m6A-containing mRNAs, YTHDF2 expedites mRNA decay, and YTHDC1 affects the nuclear processing of its targets. The biological function of YTHDC2, the final member of the YTH protein family, remains unknown. We report that YTHDC2 selectively binds m6A at its consensus motif. YTHDC2 enhances the translation efficiency of its targets and also decreases their mRNA abundance. -
'Next- Generation' Sequencing Data Analysis
Novel Algorithm Development for ‘Next- Generation’ Sequencing Data Analysis Agne Antanaviciute Submitted in accordance with the requirements for the degree of Doctor of Philosophy University of Leeds School of Medicine Leeds Institute of Biomedical and Clinical Sciences 12/2017 ii The candidate confirms that the work submitted is her own, except where work which has formed part of jointly-authored publications has been included. The contribution of the candidate and the other authors to this work has been explicitly given within the thesis where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement ©2017 The University of Leeds and Agne Antanaviciute The right of Agne Antanaviciute to be identified as Author of this work has been asserted by her in accordance with the Copyright, Designs and Patents Act 1988. Acknowledgements I would like to thank all the people who have contributed to this work. First and foremost, my supervisors Dr Ian Carr, Professor David Bonthron and Dr Christopher Watson, who have provided guidance, support and motivation. I could not have asked for a better supervisory team. I would also like to thank my collaborators Dr Belinda Baquero and Professor Adrian Whitehouse for opening new, interesting research avenues. A special thanks to Dr Belinda Baquero for all the hard wet lab work without which at least half of this thesis would not exist. Thanks to everyone at the NGS Facility – Carolina Lascelles, Catherine Daley, Sally Harrison, Ummey Hany and Laura Crinnion – for the generation of NGS data used in this work and creating a supportive and stimulating work environment. -
Datasheet Blank Template
SAN TA C RUZ BI OTEC HNOL OG Y, INC . YTHDC2 (G-19): sc-249370 BACKGROUND APPLICATIONS YTHDC2 (YTH domain containing 2), also known as probable ATP-dependent YTHDC2 (G-19) is recommended for detection of YTHDC2 of mouse, rat and RNA helicase YTHDC2, is a 1,430 amino acid protein. Belonging to the DEAD human origin by Western Blotting (starting dilution 1:200, dilution range 1:100- box helicase family and DEAH subfamily, YTHDC2 contains two ANK repeats, 1:1000), immunofluorescence (starting dilution 1:50, dilution range 1:50-1:500) a helicase ATP-binding domain, helicase C-terminal domain, R3H domain and and solid phase ELISA (starting dilution 1:30, dilution range 1:30-1:3000); non a YTH domain, a potential RNA binding domain. The gene encoding YTHDC2 cross-reactive with YTHDC1. maps to human chromosome 5q22.2 and mouse chromosome 18 B3. With YTHDC2 (G-19) is also recommended for detection of YTHDC2 in additional 181 million base pairs encoding around 1,000 genes, chromosome 5 make up species, including bovine. approximately 6% of human genomic DNA. Chromosome 5 is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous poly - Suitable for use as control antibody for YTHDC2 siRNA (h): sc-91804, YTHDC2 posis through the adenomatous polyposis coli (APC) tumor suppressor gene. siRNA (m): sc-155422, YTHDC2 shRNA Plasmid (h): sc-91804-SH, YTHDC2 Treacher Collins syndrome is also chromosome 5 associated and is caused by shRNA Plasmid (m): sc-155422-SH, YTHDC2 shRNA (h) Lentiviral Particles: insertions or deletions within the TCOF1 gene. -
Molecular Diagnostic Requisition
BAYLOR MIRACA GENETICS LABORATORIES SHIP TO: Baylor Miraca Genetics Laboratories 2450 Holcombe, Grand Blvd. -Receiving Dock PHONE: 800-411-GENE | FAX: 713-798-2787 | www.bmgl.com Houston, TX 77021-2024 Phone: 713-798-6555 MOLECULAR DIAGNOSTIC REQUISITION PATIENT INFORMATION SAMPLE INFORMATION NAME: DATE OF COLLECTION: / / LAST NAME FIRST NAME MI MM DD YY HOSPITAL#: ACCESSION#: DATE OF BIRTH: / / GENDER (Please select one): FEMALE MALE MM DD YY SAMPLE TYPE (Please select one): ETHNIC BACKGROUND (Select all that apply): UNKNOWN BLOOD AFRICAN AMERICAN CORD BLOOD ASIAN SKELETAL MUSCLE ASHKENAZIC JEWISH MUSCLE EUROPEAN CAUCASIAN -OR- DNA (Specify Source): HISPANIC NATIVE AMERICAN INDIAN PLACE PATIENT STICKER HERE OTHER JEWISH OTHER (Specify): OTHER (Please specify): REPORTING INFORMATION ADDITIONAL PROFESSIONAL REPORT RECIPIENTS PHYSICIAN: NAME: INSTITUTION: PHONE: FAX: PHONE: FAX: NAME: EMAIL (INTERNATIONAL CLIENT REQUIREMENT): PHONE: FAX: INDICATION FOR STUDY SYMPTOMATIC (Summarize below.): *FAMILIAL MUTATION/VARIANT ANALYSIS: COMPLETE ALL FIELDS BELOW AND ATTACH THE PROBAND'S REPORT. GENE NAME: ASYMPTOMATIC/POSITIVE FAMILY HISTORY: (ATTACH FAMILY HISTORY) MUTATION/UNCLASSIFIED VARIANT: RELATIONSHIP TO PROBAND: THIS INDIVIDUAL IS CURRENTLY: SYMPTOMATIC ASYMPTOMATIC *If family mutation is known, complete the FAMILIAL MUTATION/ VARIANT ANALYSIS section. NAME OF PROBAND: ASYMPTOMATIC/POPULATION SCREENING RELATIONSHIP TO PROBAND: OTHER (Specify clinical findings below): BMGL LAB#: A COPY OF ORIGINAL RESULTS ATTACHED IF PROBAND TESTING WAS PERFORMED AT ANOTHER LAB, CALL TO DISCUSS PRIOR TO SENDING SAMPLE. A POSITIVE CONTROL MAY BE REQUIRED IN SOME CASES. REQUIRED: NEW YORK STATE PHYSICIAN SIGNATURE OF CONSENT I certify that the patient specified above and/or their legal guardian has been informed of the benefits, risks, and limitations of the laboratory test(s) requested. -
X-Linked Diseases: Susceptible Females
REVIEW ARTICLE X-linked diseases: susceptible females Barbara R. Migeon, MD 1 The role of X-inactivation is often ignored as a prime cause of sex data include reasons why women are often protected from the differences in disease. Yet, the way males and females express their deleterious variants carried on their X chromosome, and the factors X-linked genes has a major role in the dissimilar phenotypes that that render women susceptible in some instances. underlie many rare and common disorders, such as intellectual deficiency, epilepsy, congenital abnormalities, and diseases of the Genetics in Medicine (2020) 22:1156–1174; https://doi.org/10.1038/s41436- heart, blood, skin, muscle, and bones. Summarized here are many 020-0779-4 examples of the different presentations in males and females. Other INTRODUCTION SEX DIFFERENCES ARE DUE TO X-INACTIVATION Sex differences in human disease are usually attributed to The sex differences in the effect of X-linked pathologic variants sex specific life experiences, and sex hormones that is due to our method of X chromosome dosage compensation, influence the function of susceptible genes throughout the called X-inactivation;9 humans and most placental mammals – genome.1 5 Such factors do account for some dissimilarities. compensate for the sex difference in number of X chromosomes However, a major cause of sex-determined expression of (that is, XX females versus XY males) by transcribing only one disease has to do with differences in how males and females of the two female X chromosomes. X-inactivation silences all X transcribe their gene-rich human X chromosomes, which is chromosomes but one; therefore, both males and females have a often underappreciated as a cause of sex differences in single active X.10,11 disease.6 Males are the usual ones affected by X-linked For 46 XY males, that X is the only one they have; it always pathogenic variants.6 Females are biologically superior; a comes from their mother, as fathers contribute their Y female usually has no disease, or much less severe disease chromosome. -
Integrated Analysis of the Critical Region 5P15.3–P15.2 Associated with Cri-Du-Chat Syndrome
Genetics and Molecular Biology, 42, 1(suppl), 186-196 (2019) Copyright © 2019, Sociedade Brasileira de Genética. Printed in Brazil DOI: http://dx.doi.org/10.1590/1678-4685-GMB-2018-0173 Research Article Integrated analysis of the critical region 5p15.3–p15.2 associated with cri-du-chat syndrome Thiago Corrêa1, Bruno César Feltes2 and Mariluce Riegel1,3* 1Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 2Institute of Informatics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 3Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. Abstract Cri-du-chat syndrome (CdCs) is one of the most common contiguous gene syndromes, with an incidence of 1:15,000 to 1:50,000 live births. To better understand the etiology of CdCs at the molecular level, we investigated theprotein–protein interaction (PPI) network within the critical chromosomal region 5p15.3–p15.2 associated with CdCs using systemsbiology. Data were extracted from cytogenomic findings from patients with CdCs. Based on clin- ical findings, molecular characterization of chromosomal rearrangements, and systems biology data, we explored possible genotype–phenotype correlations involving biological processes connected with CdCs candidate genes. We identified biological processes involving genes previously found to be associated with CdCs, such as TERT, SLC6A3, and CTDNND2, as well as novel candidate proteins with potential contributions to CdCs phenotypes, in- cluding CCT5, TPPP, MED10, ADCY2, MTRR, CEP72, NDUFS6, and MRPL36. Although further functional analy- ses of these proteins are required, we identified candidate proteins for the development of new multi-target genetic editing tools to study CdCs. -
Aspects of Sexual Dimorphism in Mammalian Meiosis
REPRODUCTIONREVIEW Focus on Meiosis Not all germ cells are created equal: Aspects of sexual dimorphism in mammalian meiosis Meisha A Morelli and Paula E Cohen Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA Correspondence should be addressed to P E Cohen; Email: [email protected] Abstract The study of mammalian meiosis is complicated by the timing of meiotic events in females and by the intermingling of meiotic sub-stages with somatic cells in the gonad of both sexes. In addition, studies of mouse mutants for different meiotic regulators have revealed significant differences in the stringency of meiotic events in males versus females. This sexual dimorphism implies that the processes of recombination and homologous chromosome pairing, while being controlled by similar genetic pathways, are subject to different levels of checkpoint control in males and females. This review is focused on the emerging picture of sexual dimorphism exhibited by mammalian germ cells using evidence from the broad range of meiotic mutants now available in the mouse. Many of these mouse mutants display distinct differences in meiotic progression and/or dysfunc- tion in males versus females, and their continued study will allow us to understand the molecular basis for the sex-specific differences observed during prophase I progression. Reproduction (2005) 130 761–781 Introduction most of the defining events that differentiate meiosis from mitosis. This includes homolog pairing as well as double Meiosis is a specialized cell division process that is essen- stranded break (DSB) formation and resolution leading to tial for the propagation of all sexually reproducing organ- crossover/recombination between homologus chromo- isms. -
Molecular Diagnosis of Glycogen Storage Disease and Disorders with Overlapping Clinical Symptoms by Massive Parallel Sequencing
© American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE Molecular diagnosis of glycogen storage disease and disorders with overlapping clinical symptoms by massive parallel sequencing Ana I Vega, PhD1,2,3, Celia Medrano, BSc1,2,3, Rosa Navarrete, BSc1,2,3, Lourdes R Desviat, PhD1,2,3, Begoña Merinero, PhD1,2,3, Pilar Rodríguez-Pombo, PhD1,2,3, Isidro Vitoria, MD, PhD4, Magdalena Ugarte, PhD1,2,3, Celia Pérez-Cerdá, PhD1,2,3 and Belen Pérez, PhD1,2,3 Purpose: Glycogen storage disease (GSD) is an umbrella term for a Results: Pathogenic mutations were detected in 23 patients. group of genetic disorders that involve the abnormal metabolism of Twenty-two mutations were recognized (mostly loss-of-function glycogen; to date, 23 types of GSD have been identified. The nonspe- mutations), including 11 that were novel in GSD-associated genes. In cific clinical presentation of GSD and the lack of specific biomarkers addition, CES detected five patients with mutations in ALDOB, LIPA, mean that Sanger sequencing is now widely relied on for making a NKX2-5, CPT2, or ANO5. Although these genes are not involved in diagnosis. However, this gene-by-gene sequencing technique is both GSD, they are associated with overlapping phenotypic characteristics laborious and costly, which is a consequence of the number of genes such as hepatic, muscular, and cardiac dysfunction. to be sequenced and the large size of some genes. Conclusions: These results show that next-generation sequenc- ing, in combination with the detection of biochemical and clinical Methods: This work reports the use of massive parallel sequencing hallmarks, provides an accurate, high-throughput means of making to diagnose patients at our laboratory in Spain using either a cus- genetic diagnoses of GSD and related diseases.